7 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... anticoagulant; LMWH = low ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... anticoagulant; LMWH, low-molecular-weight ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... and relief of dyspnea ... Note: there is a low ... Effusions #MPE #Algorithm
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... Note: there is a low ... #Algorithm #Effusion ... #Malignant #Management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
typical HF sx: dyspnea ... Avoid Warfarin and DOAC ... Delivery • Stable ... e.g., <50%), ESC guidelines ... #cardiology #treatment
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
hematological malignancy ... • Cough • Dyspnea ... Hodgkin Lymphoma Treatment ... classification #hematology ... #oncology #management
Management of Pruritus in Patients with Chronic Kidney Disease
Pruritus with no primary lesions - differential diagnosis:
pruritus • Hematologic ... acupuncture • Malignancy ... #Pruritus #Treatment ... #Algorithm #Hemodialysis ... #Nephrology #CKD